Interaction and Efficacy of Keigai-rengyo-to Extract and Acupuncture in Male Patients with Acne Vulgaris: a Study Protocol for a Randomized Controlled Pilot Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2011 Mar 23

PMID 21418585

Citations 1

Authors

Kyu Seok Kim

Yoon-Bum Kim

Affiliations

Soon will be listed here.

Abstract

Background: In consideration of patients seeking to use traditional Chinese medicine, an evidence-based potentiality for safe and effective use of herbal medicine and acupuncture in treatment of acne vulgaris has been suggested. However, despite common use of a combination of herbal medicine and acupuncture in clinical practice, the current level of evidence is insufficient to draw a conclusion for an interaction and efficacy of herbal medicine and acupuncture. Therefore, considering these methodological flaws, this study was designed to assess the interaction and efficacy of an available herbal medicine, Keigai-rengyo-to extract (KRTE), and acupuncture for treatment of acne using the 2 × 2 factorial design and the feasibility of a large clinical trial.

Methods/design: A randomized, assessor single blinded, 2 × 2 factorial pilot trial will be conducted. Forty four participants with acne vulgaris will be randomized into one of four groups: waiting list group (WL), KRTE only group (KO), acupuncture only group (AO), and KRTE and acupuncture combined treatment group (KA). After randomization, a total of 8 sessions of acupuncture treatment will be performed twice a week in the AO- and KA groups, respectively. Patients in the KO- and KA groups will be prescribed KRTE 3 times a day at a dose of 7.4 g after meals for 4 weeks. The following outcome measurements will be used in examination of subjects: the mean percentage change and the count change of inflammatory and non-inflammatory acne lesions, the Skindex 29, visual analogue scale (VAS) and investigator global assessment (IGA) from baseline to the end of the trial.

Trial Registration: The trial is registered with the Clinical Research Information Service (CRiS), Republic of Korea: KCT0000071.

Citing Articles

Acupuncture for Acne Vulgaris: A Systematic Review and Meta-Analysis.

Mansu S, Liang H, Parker S, Coyle M, Wang K, Zhang A Evid Based Complement Alternat Med. 2018; 2018:4806734.

PMID: 29721027 PMC: 5867647. DOI: 10.1155/2018/4806734.

References

Shamban A, Narurkar V . Multimodal treatment of acne, acne scars and pigmentation. Dermatol Clin. 2009; 27(4):459-71, vi. DOI: 10.1016/j.det.2009.08.010. View

Dai G . Advances in the acupuncture treatment of acne. J Tradit Chin Med. 1997; 17(1):65-72. View

Geria A, Tajirian A, Kihiczak G, Schwartz R . Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat. 2009; 17(2):123-6. View

Gorpelioglu C, Ozol D, Sarifakioglu E . Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris. Int J Dermatol. 2010; 49(1):87-90. DOI: 10.1111/j.1365-4632.2009.04232.x. View

Katsambas A, Stefanaki C, Cunliffe W . Guidelines for treating acne. Clin Dermatol. 2004; 22(5):439-44. DOI: 10.1016/j.clindermatol.2004.03.002. View

Stern R . The prevalence of acne on the basis of physical examination. J Am Acad Dermatol. 1992; 26(6):931-5. DOI: 10.1016/0190-9622(92)70135-3. View

Del Rosso J, Kim G . Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin. 2008; 27(1):33-42. DOI: 10.1016/j.det.2008.07.006. View

Koo J, Desai R . Traditional Chinese medicine in dermatology. Dermatol Ther. 2003; 16(2):98-105. DOI: 10.1046/j.1529-8019.2003.01617.x. View

McLane J . Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001; 45(5):S188-94. DOI: 10.1067/mjd.2001.113719. View

10.

Leyden J, Shalita A, Hordinsky M, Swinyer L, Stanczyk F, Weber M . Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial. J Am Acad Dermatol. 2002; 47(3):399-409. DOI: 10.1067/mjd.2002.122192. View

11.

Bettoli V, Sarno O, Zauli S, Borghi A, Minghetti S, Ricci M . [What's new in acne? New therapeutic approaches]. Ann Dermatol Venereol. 2010; 137 Suppl 2:S81-5. DOI: 10.1016/S0151-9638(10)70033-8. View

12.

Lolis M, Bowe W, Shalita A . Acne and systemic disease. Med Clin North Am. 2009; 93(6):1161-81. DOI: 10.1016/j.mcna.2009.08.008. View

13.

Arowojolu A, Gallo M, Lopez L, Grimes D, Garner S . Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2007; (1):CD004425. DOI: 10.1002/14651858.CD004425.pub3. View

14.

Yin R, Hao F, Deng J, Yang X, Yan H . Investigation of optimal aminolaevulinic acid concentration applied in topical aminolaevulinic acid-photodynamic therapy for treatment of moderate to severe acne: a pilot study in Chinese subjects. Br J Dermatol. 2010; 163(5):1064-71. DOI: 10.1111/j.1365-2133.2010.09860.x. View

15.

Costa A, Lage D, Moises T . Acne and diet: truth or myth?. An Bras Dermatol. 2010; 85(3):346-53. DOI: 10.1590/s0365-05962010000300008. View

16.

Koo J, Arain S . Traditional Chinese medicine for the treatment of dermatologic disorders. Arch Dermatol. 1998; 134(11):1388-93. DOI: 10.1001/archderm.134.11.1388. View

17.

Nie Y, Wang C . A survey of treatment of acne by acupuncture. J Tradit Chin Med. 2008; 28(1):71-4. DOI: 10.1016/s0254-6272(08)60017-5. View

18.

Vickers A . How to randomize. J Soc Integr Oncol. 2006; 4(4):194-8. PMC: 2596474. DOI: 10.2310/7200.2006.023. View

19.

Leyden J, Del Rosso J, Webster G . Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin. 2008; 27(1):1-15. DOI: 10.1016/j.det.2008.07.008. View

20.

Koltun W, Lucky A, Thiboutot D, Niknian M, Sampson-Landers C, Korner P . Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception. 2008; 77(4):249-56. DOI: 10.1016/j.contraception.2007.11.003. View